Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1819021000168111 | Candesartan HCT 32/12.5 (Alphapharm) (candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1819031000168114 | Candesartan HCT 32/12.5 (Alphapharm) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Candesartan HCT 32/12.5 (Alphapharm) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Candesartan HCT 32/12.5 (Alphapharm) tablet | Is a | candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | ||
| Candesartan HCT 32/12.5 (Alphapharm) tablet | Is a | Candesartan HCT 32/12.5 (Alphapharm) | true | Inferred relationship | Some | ||
| Candesartan HCT 32/12.5 (Alphapharm) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Candesartan HCT 32/12.5 (Alphapharm) tablet | has unit of use | tablet | true | Inferred relationship | Some | 1136344312 | |
| Candesartan HCT 32/12.5 (Alphapharm) tablet | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 715285262 | |
| Candesartan HCT 32/12.5 (Alphapharm) tablet | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 715285262 | |
| Candesartan HCT 32/12.5 (Alphapharm) tablet | has Australian BoSS | candesartan cilexetil | true | Inferred relationship | Some | 1136344311 | |
| Candesartan HCT 32/12.5 (Alphapharm) tablet | has intended active ingredient | candesartan | true | Inferred relationship | Some | 1136344311 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Candesartan HCT 32/12.5 (Alphapharm) tablet, 7 | has TPUU | True | Candesartan HCT 32/12.5 (Alphapharm) tablet | Inferred relationship | Some | 1 |
| Candesartan HCT 32/12.5 (Alphapharm) tablet, 30 | has TPUU | True | Candesartan HCT 32/12.5 (Alphapharm) tablet | Inferred relationship | Some | 1 |
| Candesartan HCT 32/12.5 (Alphapharm) tablet, 7, bottle | has TPUU | True | Candesartan HCT 32/12.5 (Alphapharm) tablet | Inferred relationship | Some | 1 |
| Candesartan HCT 32/12.5 (Alphapharm) tablet, 7, blister pack | has TPUU | True | Candesartan HCT 32/12.5 (Alphapharm) tablet | Inferred relationship | Some | 1 |
| Candesartan HCT 32/12.5 (Alphapharm) tablet, 30, bottle | has TPUU | True | Candesartan HCT 32/12.5 (Alphapharm) tablet | Inferred relationship | Some | 1 |
| Candesartan HCT 32/12.5 (Alphapharm) tablet, 30, blister pack | has TPUU | True | Candesartan HCT 32/12.5 (Alphapharm) tablet | Inferred relationship | Some | 1 |
Reference Sets
Description inactivation indicator reference set
Trade product unit of use reference set
FHIR